insights_auto
Kwa nini LAURUSLABS imeongezeka kwa 2.06%?
Fahamu zaidichevron_right
LAURUSLABS:NSE
Laurus Labs Ltd
₹ 2,060.10
arrow_upward
+2.06%(+41.60) Siku 1
16 Okt, 15:30:00 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya LAURUSLABS...
Fungua
₹ 2,030.40
Juu
₹ 2,086.00
Chini
₹ 2,028.70
Mtaji wa soko
1.11T
Wastani wa kiasi cha mauzo
1.58M
Kiasi cha mauzo ya hisa
1.61M
Gawio
0.10%
Mgawo wa faida wa kila robo mwaka
₹ 0.50
Tarehe ya kutojumuisha gawio
8 Mei 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
101.86
Juu kwa wiki 52
₹ 2,086.00
Chini kwa wiki 52
₹ 870.45
EPS
₹ 20.23
Hisa za wawekezaji
106.44M
Idadi ya wafanyakazi
elfu 7
Fungua
₹ 2,030.40
Juu
₹ 2,086.00
Chini
₹ 2,028.70
Mtaji wa soko
1.11T
Wastani wa kiasi cha mauzo
1.58M
Kiasi cha mauzo ya hisa
1.61M
Gawio
0.10%
Mgawo wa faida wa kila robo mwaka
₹ 0.50
Tarehe ya kutojumuisha gawio
8 Mei 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
101.86
Juu kwa wiki 52
₹ 2,086.00
Chini kwa wiki 52
₹ 870.45
EPS
₹ 20.23
Hisa za wawekezaji
106.44M
Idadi ya wafanyakazi
elfu 7
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
GlobeNewswire
·
saa 1 iliyopita
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
www.marketscreener.com
·
dakika 26 zilizopita
Inter & Co, Inc.(NasdaqGS: INTR) added to S&P Global BMI Index
FXLeaders
·
dakika 28 zilizopita
Nasdaq and Dow Futures Recover Ealy Monday Ahead of Meta, Tesla and SpaceX Earnings as Iran De-escalation Hopes Lift Sentiment
Bloomberg.com
·
saa 3 zilizopita
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Wasifu
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Kuhusu Laurus Labs Ltd
Afisa Mkuu Mtendaji (CEO)Satyanarayana Chava
Wafanyakazielfu 7.06
Lilianzishwa2005
Makao makuu-
Sekta-
Tovutilauruslabs.com